S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Log in

Magellan Health Stock Forecast, Price & News

0.00 (0.00 %)
(As of 01/15/2021 12:00 AM ET)
Today's Range
Now: $94.55
50-Day Range
MA: $83.84
52-Week Range
Now: $94.55
Volume705,539 shs
Average Volume561,401 shs
Market Capitalization$2.42 billion
P/E Ratio17.74
Dividend YieldN/A
Magellan Health, Inc., together with its subsidiaries, provides healthcare management services in the United States. The company operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans (EAP); and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine. It also contracts with state Medicaid agencies, and the centers for Medicare and Medicaid services to manage care for beneficiaries under Medicaid and Medicare programs, such as healthcare and long-term support services through its network of medical and behavioral health professionals, clinics, hospitals, nursing facilities, home care agencies, and ancillary service providers. The Pharmacy Management segment comprises products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Further, it offers pharmacy benefit management services, such as pharmaceutical dispensing services; pharmacy benefit administration for state Medicaid and other government sponsored programs; clinical and formulary management programs; medical pharmacy management programs; and programs for the integrated management of specialty drugs that treat complex conditions. In addition, the company provides services to health plans and other managed care organizations, employers, labor unions, various military and governmental agencies, and third party administrators. Magellan Health, Inc. was incorporated in 1969 and is headquartered in Phoenix, Arizona.
Magellan Health logo


Overall MarketRank

1.67 out of 5 stars

Medical Sector

197th out of 1,558 stocks

Hospitals Industry

2nd out of 6 stocks

Analyst Opinion: 1.2Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 3.1 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Hospitals
Sub-IndustryManaged Health Care
Current SymbolNASDAQ:MGLN



Sales & Book Value

Annual Sales$7.16 billion
Cash Flow$9.12 per share
Book Value$57.13 per share


Net Income$55.90 million


Market Cap$2.42 billion
Next Earnings Date2/26/2021 (Estimated)
0.00 (0.00 %)
(As of 01/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MGLN News and Ratings via Email

Sign-up to receive the latest news and ratings for MGLN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Magellan Health (NASDAQ:MGLN) Frequently Asked Questions

How has Magellan Health's stock price been impacted by COVID-19 (Coronavirus)?

Magellan Health's stock was trading at $53.88 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, MGLN shares have increased by 75.5% and is now trading at $94.55.
View which stocks have been most impacted by COVID-19

Is Magellan Health a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Magellan Health in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Magellan Health stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MGLN, but not buy additional shares or sell existing shares.
View analyst ratings for Magellan Health
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Magellan Health?

Wall Street analysts have given Magellan Health a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Magellan Health wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Magellan Health's next earnings date?

Magellan Health is scheduled to release its next quarterly earnings announcement on Friday, February 26th 2021.
View our earnings forecast for Magellan Health

How were Magellan Health's earnings last quarter?

Magellan Health, Inc. (NASDAQ:MGLN) released its quarterly earnings data on Thursday, October, 29th. The company reported $0.08 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.12) by $0.20. The business earned $1.17 billion during the quarter, compared to analyst estimates of $1.14 billion. Magellan Health had a net margin of 2.28% and a return on equity of 5.57%. The firm's revenue was up 1.0% compared to the same quarter last year. During the same period last year, the business earned $1.23 earnings per share.
View Magellan Health's earnings history

What guidance has Magellan Health issued on next quarter's earnings?

Magellan Health updated its FY20 earnings guidance on Thursday, October, 29th. The company provided EPS guidance of $0.63-1.10 for the period, compared to the Thomson Reuters consensus estimate of $0.91. The company issued revenue guidance of $4.40-4.60 billion, compared to the consensus revenue estimate of $4.50 billion.

What price target have analysts set for MGLN?

3 analysts have issued 1-year price targets for Magellan Health's shares. Their forecasts range from $90.00 to $95.00. On average, they anticipate Magellan Health's share price to reach $93.33 in the next year. This suggests that the stock has a possible downside of 1.3%.
View analysts' price targets for Magellan Health
or view Wall Street analyst' top-rated stocks.

Are investors shorting Magellan Health?

Magellan Health saw a increase in short interest in December. As of December 31st, there was short interest totaling 506,200 shares, an increase of 29.8% from the December 15th total of 390,000 shares. Based on an average daily trading volume, of 131,300 shares, the short-interest ratio is currently 3.9 days.
View Magellan Health's Short Interest

Who are some of Magellan Health's key competitors?

What other stocks do shareholders of Magellan Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Magellan Health investors own include Energy Transfer (ET), General Motors (GM), NVIDIA (NVDA), The Boeing (BA), Netflix (NFLX), UnitedHealth Group (UNH), Broadcom (AVGO), Mastercard (MA), Ford Motor (F) and Overstock.com (OSTK).

Who are Magellan Health's key executives?

Magellan Health's management team includes the following people:
  • Mr. Kenneth John Fasola, CEO & Director (Age 61, Pay $880.77k)
  • Ms. Caskie Lewis-Clapper, Chief HR Officer (Age 56, Pay $724.94k)
  • Mr. Mostafa M. Kamal, Chief Exec. Officer of Magellan Rx Management (Age 40, Pay $983.94k)
  • Mr. James Elmer Murray, Pres & COO (Age 67)
  • Mr. David Patrick Bourdon, Chief Financial Officer
  • Ms. Renie Shapiro Silver, SVP - Corp. Fin.
  • Mr. Darren P. Lehrich, Chief Investor Relations Officer (Age 49)
  • Mr. David Haddock, Gen. Counsel & Sec. (Age 51)
  • Mr. John E. Littel, Chief External Affairs Officer (Age 56)
  • Mr. Jay Youell, Sr. VP of Sales - Health Plan & Insurance Markets

What is Magellan Health's stock symbol?

Magellan Health trades on the NASDAQ under the ticker symbol "MGLN."

Who are Magellan Health's major shareholders?

Magellan Health's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include State of Alaska Department of Revenue (0.07%), Crossmark Global Holdings Inc. (0.02%) and Diversified Trust Co (0.01%). Company insiders that own Magellan Health stock include James E Murray, Jeffrey N West and Mostafa Kamal.
View institutional ownership trends for Magellan Health

Which institutional investors are selling Magellan Health stock?

MGLN stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, and Crossmark Global Holdings Inc.. Company insiders that have sold Magellan Health company stock in the last year include Jeffrey N West, and Mostafa Kamal.
View insider buying and selling activity for Magellan Health
or view top insider-selling stocks.

Which institutional investors are buying Magellan Health stock?

MGLN stock was bought by a variety of institutional investors in the last quarter, including Diversified Trust Co.
View insider buying and selling activity for Magellan Health
or or view top insider-buying stocks.

How do I buy shares of Magellan Health?

Shares of MGLN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Magellan Health's stock price today?

One share of MGLN stock can currently be purchased for approximately $94.55.

How big of a company is Magellan Health?

Magellan Health has a market capitalization of $2.42 billion and generates $7.16 billion in revenue each year. The company earns $55.90 million in net income (profit) each year or $3.73 on an earnings per share basis. Magellan Health employs 10,100 workers across the globe.

What is Magellan Health's official website?

The official website for Magellan Health is www.magellanhealth.com.

How can I contact Magellan Health?

Magellan Health's mailing address is 4801 E. Washington Street, Phoenix AZ, 85034. The company can be reached via phone at 800-642-1716 or via email at [email protected]

This page was last updated on 1/16/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.